BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou Q, Andersson R, Hu D, Bauden M, Kristl T, Sasor A, Pawłowski K, Pla I, Hilmersson KS, Zhou M, Lu F, Marko-Varga G, Ansari D. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue. EBioMedicine 2019;43:282-94. [PMID: 30982764 DOI: 10.1016/j.ebiom.2019.04.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Pan X, Xu X, Wang L, Zhang S, Chen Y, Yang R, Chen X, Cheng B, Xia J, Ren X. BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1021262] [Reference Citation Analysis]
2 Manouchehri Doulabi E, Fredolini C, Gallini R, Löf L, Shen Q, Ikebuchi R, Dubois L, Azimi A, Loudig O, Gabrielsson S, Landegren U, Larsson A, Bergquist J, Kamali-Moghaddam M. Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays. Commun Biol 2022;5:1402. [PMID: 36550367 DOI: 10.1038/s42003-022-04349-x] [Reference Citation Analysis]
3 Yu S, E C, Yang J. STAM binding protein regulated by hsa_circ_0007334 exerts oncogenic potential in pancreatic cancer. Pancreatology 2022;22:1003-12. [PMID: 36089485 DOI: 10.1016/j.pan.2022.08.010] [Reference Citation Analysis]
4 Pilotti E, Cassetti T, Mirante VG, Sereni G, Rossi PG, Sassatelli R. Exhaled breath condensate proteomic signatures potentially distinguish adenocarcinoma from benign cystic lesions of the pancreas. Curr Res Transl Med 2022;70:103361. [PMID: 35963150 DOI: 10.1016/j.retram.2022.103361] [Reference Citation Analysis]
5 Zhang Y, Dreyer B, Govorukhina N, Heberle AM, Končarević S, Krisp C, Opitz CA, Pfänder P, Bischoff R, Schlüter H, Kwiatkowski M, Thedieck K, Horvatovich PL. Comparative Assessment of Quantification Methods for Tumor Tissue Phosphoproteomics. Anal Chem 2022. [PMID: 35880733 DOI: 10.1021/acs.analchem.2c01036] [Reference Citation Analysis]
6 Lee S, Lee GS, Moon JH, Jung J. Policosanol suppresses tumor progression in a gastric cancer xenograft model. Toxicol Res . [DOI: 10.1007/s43188-022-00139-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Du T, Zhang K, Zhang Z, Guo A, Yu G, Xu Y. ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway. Braz J Med Biol Res 2022;55:e11989. [PMID: 35584452 DOI: 10.1590/1414-431X2022e11989] [Reference Citation Analysis]
8 Pacheco VB, Nery G, Fernandes LL, Santana TV, Jimenez M, Borges L, Hatanaka E, Braga P, Monteiro FR, Amaral JB, Alves LS, Bachi ALL, da Silva SG, Birbrair A, Heller D, González A. Salivary Proteome, Inflammatory, and NETosis Biomarkers in Older Adult Practitioners and Nonpractitioners of Physical Exercise. Oxidative Medicine and Cellular Longevity 2022;2022:1-10. [DOI: 10.1155/2022/3725056] [Reference Citation Analysis]
9 Weke K, Kote S, Faktor J, Al Shboul S, Uwugiaren N, Brennan PM, Goodlett DR, Hupp TR, Dapic I. DIA-MS proteome analysis of formalin-fixed paraffin-embedded glioblastoma tissues. Analytica Chimica Acta 2022. [DOI: 10.1016/j.aca.2022.339695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Dey S, Ahmed E, Somvanshi PS, Sina AAI, Wuethrich A, Trau M. An Electrochemical and Raman Scattering Dual Detection Biosensor for Rapid Screening and Biomolecular Profiling of Cancer Biomarkers. Chemosensors 2022;10:93. [DOI: 10.3390/chemosensors10030093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhang Y, Dreyer B, Govorukhina N, Heberle AM, Končarević S, Krisp C, Opitz CA, Pfänder P, Bischoff R, Schlüter H, Kwiatkowski M, Thedieck K, Horvatovich PL. Comparative assessment of quantification methods for tumor tissue phosphoproteomics.. [DOI: 10.1101/2022.02.07.479414] [Reference Citation Analysis]
12 Bao H, Li X, Cao Z, Huang Z, Chen L, Wang M, Hu J, Li W, Sun H, Jiang X, Mei P, Li H, Lu L, Zhan M. Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verification. J Transl Med 2022;20:18. [PMID: 34991628 DOI: 10.1186/s12967-021-03218-1] [Reference Citation Analysis]
13 Li Y, Wu T, Jiao Z, Yang A. BASP1 is up-regulated in tongue squamous cell carcinoma and associated with a poor prognosis. Asian J Surg 2021:S1015-9584(21)00517-0. [PMID: 34531104 DOI: 10.1016/j.asjsur.2021.08.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Miles HN, Delafield DG, Li L. Recent Developments and Applications of Quantitative Proteomics Strategies for High-Throughput Biomolecular Analyses in Cancer Research. RSC Chem Biol 2021;4:1050-72. [PMID: 34430874 DOI: 10.1039/d1cb00039j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang X, Cao Y, BoPan B, Meng Q, Yu Y. High BASP1 Expression is Associated with Poor Prognosis and Promotes Tumor Progression in Human Lung Adenocarcinoma. Cancer Invest 2021;39:409-22. [PMID: 33813994 DOI: 10.1080/07357907.2021.1910290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sohrabi E, Rezaie E, Heiat M, Sefidi-Heris Y. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer. Biochem Genet 2021. [PMID: 33813720 DOI: 10.1007/s10528-021-10062-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
17 Belali T, Wodi C, Clark B, Cheung MK, Craig TJ, Wheway G, Wagner N, Wagner KD, Roberts S, Porazinski S, Ladomery M. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1. Biochim Biophys Acta Gene Regul Mech 2020;1863:194642. [PMID: 33017668 DOI: 10.1016/j.bbagrm.2020.194642] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
18 Huang B, Trujillo MA, Fujikura K, Qiu M, Chen F, Felsenstein M, Zhou C, Skaro M, Gauthier C, Macgregor-Das A, Hutchings D, Hong SM, Hruban RH, Eshleman JR, Thompson ED, Klein AP, Goggins M, Wood LD, Roberts NJ. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms. J Pathol 2020;252:252-62. [PMID: 32696980 DOI: 10.1002/path.5515] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
19 Wei N, Song Y, Zhang F, Sun Z, Zhang X. Transcriptome Profiling of Acquired Gefitinib Resistant Lung Cancer Cells Reveals Dramatically Changed Transcription Programs and New Treatment Targets. Front Oncol 2020;10:1424. [PMID: 32923394 DOI: 10.3389/fonc.2020.01424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
20 Meleady P, Abdul Rahman R, Henry M, Moriarty M, Clynes M. Proteomic analysis of pancreatic ductal adenocarcinoma. Expert Rev Proteomics 2020;17:453-67. [PMID: 32755290 DOI: 10.1080/14789450.2020.1803743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sahni S, Krisp C, Molloy MP, Nahm C, Maloney S, Gillson J, Gill AJ, Samra J, Mittal A. PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progression. Biochim Biophys Acta Gen Subj 2020;1864:129682. [PMID: 32663515 DOI: 10.1016/j.bbagen.2020.129682] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
22 Dick JM. Water as a reactant in the differential expression of proteins in cancer.. [DOI: 10.1101/2020.04.09.035022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Ma N, Hu J, Zhang ZM, Liu W, Huang M, Fan Y, Yin X, Wang J, Ding K, Ye W, Li Z. 2H-Azirine-Based Reagents for Chemoselective Bioconjugation at Carboxyl Residues Inside Live Cells. J Am Chem Soc 2020;142:6051-9. [PMID: 32159959 DOI: 10.1021/jacs.9b12116] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
24 Zhou Q, Bauden M, Andersson R, Hu D, Marko-Varga G, Xu J, Sasor A, Dai H, Pawłowski K, Said Hilmersson K, Chen X, Ansari D. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling. J Transl Med 2020;18:77. [PMID: 32054505 DOI: 10.1186/s12967-020-02254-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
25 Hartl M, Puglisi K, Nist A, Raffeiner P, Bister K. The brain acid-soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin. Mol Oncol 2020;14:625-44. [PMID: 31944520 DOI: 10.1002/1878-0261.12636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Kowalczyk T, Ciborowski M, Kisluk J, Kretowski A, Barbas C. Mass spectrometry based proteomics and metabolomics in personalized oncology. Biochim Biophys Acta Mol Basis Dis 2020;1866:165690. [PMID: 31962175 DOI: 10.1016/j.bbadis.2020.165690] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
27 Su Y, Xue T, Wu L, Hu Y, Wang J, Xu Q, Chen Y, Lin Z. Label-free detection of biomarker alpha fetoprotein in serum by ssDNA aptamer functionalized magnetic nanoparticles. Nanotechnology 2020;31:095104. [PMID: 31726443 DOI: 10.1088/1361-6528/ab57f7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 O'Rourke MB, Town SEL, Dalla PV, Bicknell F, Koh Belic N, Violi JP, Steele JR, Padula MP. What is Normalization? The Strategies Employed in Top-Down and Bottom-Up Proteome Analysis Workflows. Proteomes 2019;7:29. [PMID: 31443461 DOI: 10.3390/proteomes7030029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
29 Manfredi M, Brandi J, Di Carlo C, Vita Vanella V, Barberis E, Marengo E, Patrone M, Cecconi D. Mining cancer biology through bioinformatic analysis of proteomic data. Expert Rev Proteomics 2019;16:733-47. [PMID: 31398064 DOI: 10.1080/14789450.2019.1654862] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
30 Karasawa R, Jarvis JN. Using the tools of proteomics to understand the pathogenesis of idiopathic inflammatory myopathies. Curr Opin Rheumatol 2019;31:617-22. [PMID: 31385878 DOI: 10.1097/BOR.0000000000000643] [Reference Citation Analysis]
31 Zhou Q, Andersson R, Hu D, Bauden M, Sasor A, Bygott T, PawŁowski K, Pla I, Marko-Varga G, Ansari D. Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis. Transl Res 2019;212:67-79. [PMID: 31295437 DOI: 10.1016/j.trsl.2019.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
32 van der Burgt YEM. Protein biomarker discovery is still relevant and has entered a new phase. EBioMedicine 2019;43:15. [PMID: 31005515 DOI: 10.1016/j.ebiom.2019.04.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]